These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7982944)

  • 1. Decreased binding of apolipoprotein (a) to familial defective apolipoprotein B-100 (Arg3500-->Gln). A study of the assembly of recombinant apolipoprotein (a) with mutant low density lipoproteins.
    Durovic S; März W; Frank S; Scharnagl H; Baumstark MW; Zechner R; Kostner GM
    J Biol Chem; 1994 Dec; 269(48):30320-5. PubMed ID: 7982944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
    Gabel BR; Koschinsky ML
    Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous familial defective apolipoprotein B-100. Enhanced removal of apolipoprotein E-containing VLDLs and decreased production of LDLs.
    Schaefer JR; Scharnagl H; Baumstark MW; Schweer H; Zech LA; Seyberth H; Winkler K; Steinmetz A; März W
    Arterioscler Thromb Vasc Biol; 1997 Feb; 17(2):348-53. PubMed ID: 9081691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) in subjects with familial defective apolipoprotein B100.
    Perombelon YF; Gallagher JJ; Myant NB; Soutar AK; Knight BL
    Atherosclerosis; 1992 Feb; 92(2-3):203-12. PubMed ID: 1385954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B-100.
    Schewe CK; Schuster H; Hailer S; Wolfram G; Keller C; Zöllner N
    Eur J Clin Invest; 1994 Jan; 24(1):36-41. PubMed ID: 8187806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function.
    Myant NB; Gallagher JJ; Knight BL; McCarthy SN; Frostegård J; Nilsson J; Hamsten A; Talmud P; Humphries SE
    Arterioscler Thromb; 1991; 11(3):691-703. PubMed ID: 1674216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased clearance of low density lipoprotein precursors in patients with heterozygous familial defective apolipoprotein B-100: a stable isotope approach.
    Pietzsch J; Wiedemann B; Julius U; Nitzsche S; Gehrisch S; Bergmann S; Leonhardt W; Jaross W; Hanefeld M
    J Lipid Res; 1996 Oct; 37(10):2074-87. PubMed ID: 8906585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects.
    Arnold KS; Balestra ME; Krauss RM; Curtiss LK; Young SG; Innerarity TL
    J Lipid Res; 1994 Aug; 35(8):1469-76. PubMed ID: 7989871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients.
    Ceska R; Vrablík M; Horínek A
    Physiol Res; 2000; 49 Suppl 1():S125-30. PubMed ID: 10984082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
    März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
    J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins.
    Trieu VN; Zioncheck TF; Lawn RM; McConathy WJ
    J Biol Chem; 1991 Mar; 266(9):5480-5. PubMed ID: 1848551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of very low density lipoprotein remnants to the low density lipoprotein receptor in familial defective apolipoprotein B-100.
    Maher VM; Gallagher JJ; Myant NB
    Atherosclerosis; 1993 Aug; 102(1):51-61. PubMed ID: 8257452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100.
    Koschinsky ML; Côté GP; Gabel B; van der Hoek YY
    J Biol Chem; 1993 Sep; 268(26):19819-25. PubMed ID: 8366120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of 46 heterozygous carriers and 57 unaffected relatives in five Danish families with familial defective apolipoprotein B-100.
    Hansen PS; Meinertz H; Jensen HK; Fruergaard P; Launbjerg J; Klausen IC; Lemming L; Gerdes U; Gregersen N; Faergeman O
    Arterioscler Thromb; 1994 Feb; 14(2):207-13. PubMed ID: 8305410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
    Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL
    J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the presence of the 3500 mutant apolipoprotein B-100 in low density lipoprotein particles affect their atherogenicity?
    Maher VM; Gallagher JJ; Thompson GR; Myant NB
    Atherosclerosis; 1995 Nov; 118(1):105-10. PubMed ID: 8579620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial defective apolipoprotein B-100 (FDB): effect of simvastatin therapy on LDL-receptor binding.
    Mamotte CD; Sturm M; Foo JI; van Bockxmeer FM; Taylor RR
    Atherosclerosis; 1996 Aug; 125(1):103-10. PubMed ID: 8831932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.
    Davignon J; Dufour R; Roy M; Bétard C; Ma Y; Ouellette S; Boulet L; Lussier-Cacan S
    Eur J Epidemiol; 1992 May; 8 Suppl 1():10-7. PubMed ID: 1505645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial defective apolipoprotein B-100.
    Hansen PS
    Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.